On the stock market since 2009, it operates in the world of health and science. Now — the numbers.
This is an established company with proven profits.
If every debt were paid off today, $79K would still be left in the vault — a solid cushion for hard times.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The net profit margin is 41% — still a thick cushion, though costs have been eating into it lately.
Over the last 3 years, sales grew about 51% a year on average.
There is $79K in the vault; even if every debt were paid off, $79K would remain.
The stock sits at $0.0002. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, SYUP sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: SYUP is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.